STAT+: Halfway into the year, biotech is booming
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- XBI biotech index gained 19% over the past month, delivering what the source calls a "bonkers" June for the sector.
- XBI is up 30% year-to-date at the halfway mark of the year, per Adam's Biotech Scorecard.
- The XBI is trading at 158, reaching a five-year high for the benchmark.
- The index is now approaching its previous peak of $175, set in February 2021.
Why it matters: The XBI's 30% year-to-date gain and 19% monthly surge puts biotech within $17 of its February 2021 peak — the height of the pandemic-era boom. Investors who held through the subsequent multi-year downturn are now seeing meaningful recovery, and a return to $175 would mark the index fully erasing its post-2021 losses.
